PreSIRT bevacizumab does not affect outcomes in patients with non-colorectal cancer metastatic to the liver.
SIR ePoster library. Xu D. 03/17/18; 208868; 696
David Xu
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}